Abstract:The nano‐sized extracellular matrix is conjugated with doxorubicin using cis‐aconitic anhydride to prepare extracellular matrix‐drug conjugates, endowing them with acid‐sensitive drug release properties. These conjugates can be internalized into tumor cells via hyaluronic acid receptors and integrins, enhancing tumor site accumulation and antitumor efficacy while reducing organ toxicity of doxorubicin. The extracellular matrix (ECM) engages in regulatory interactions with cell surface receptors through its constituent proteins and polysaccharides. Therefore, nano‐sized extracellular matrix conjugated with doxorubicin (DOX) is utilized to produce extracellular matrix‐drug conjugates (ECM‐DOX) tailored for targeted delivery to cancer cells. The ECM‐DOX nanoparticles exhibit rod‐like morphology, boasting a commendable drug loading capacity of 4.58%, coupled with acid‐sensitive drug release characteristics. Notably, ECM‐DOX nanoparticles enhance the uptake by tumor cells and possess the ability to penetrate endothelial cells and infiltrate tumor multicellular spheroids. Mechanistic insights reveal that the internalization of ECM‐DOX nanoparticle is facilitated through clathrin‐mediated endocytosis and macropinocytosis, intricately involving hyaluronic acid receptors and integrins. Pharmacokinetic assessments unveil a prolonged blood half‐life of ECM‐DOX nanoparticles at 3.65 h, a substantial improvement over the 1.09 h observed for free DOX. A sustained accumulation effect of ECM‐DOX nanoparticles at tumor sites, with drug levels in tumor tissues surpassing those of free DOX by several‐fold. The profound therapeutic impact of ECM‐DOX nanoparticles is evident in their notable inhibition of tumor growth, extension of median survival time in animals, and significant reduction in DOX‐induced cardiotoxicity. The ECM platform emerges as a promising carrier for avant‐garde nanomedicines in the realm of cancer treatment.

Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy

Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Nanomedicine Disrupts Stromal Barriers to Augment Drug Penetration for Improved Cancer Therapy

Effect of biophysical properties of tumor extracellular matrix on intratumoral fate of nanoparticles: Implications on the design of nanomedicine

Biomaterials to regulate tumor extracellular matrix in immunotherapy

Enhanced Intracellular Transcytosis of Nanoparticles by Degrading Extracellular Matrix for Deep Tissue Radiotherapy of Pancreatic Adenocarcinoma

Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management

Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery

Enhanced Tumor Site Accumulation and Therapeutic Efficacy of Extracellular Matrix‐Drug Conjugates Targeting Tumor Cells

Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer

Extracellular Matrix Modulating Enzyme Functionalized Biomimetic Au Nanoplatform-Mediated Enhanced Tumor Penetration and Synergistic Antitumor Therapy for Pancreatic Cancer

Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy

Nanoparticulates Reduce Tumor Cell Migration Through Affinity Interactions with Extracellular Migrasomes and Retraction Fibers.

Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance

Modulating Tumor Extracellular Matrix by Simultaneous Inhibition of Two Cancer Cell Receptors.

Erythrocyte Membrane Camouflaged Metal–Organic Framework Nanodrugs for Remodeled Tumor Microenvironment and Enhanced Tumor Chemotherapy

Strategies to improve tumor penetration of nanomedicines through nanoparticle design

Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems

Stromal Barriers and Strategies for the Delivery of Nanomedicine to Desmoplastic Tumors

Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer

Vascular and extracellular matrix remodeling by physical approaches to improve drug delivery at the tumor site